Z. Li

发表

Characterization of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques.

L. Foresman, S. Joag, O. Narayan, 1999, Virology.

Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques.

R. Doms, C. Tian, V. Gattone, 1999, Virology.

Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.

J. Lifson, O. Narayan, P. Silverstein, 2000, Virology.

A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism.

S. Joag, R. Raghavan, O. Narayan, 1997, Virology.

Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques.

L. Foresman, D. Pinson, S. Joag, 1997, AIDS research and human retroviruses.

Failure of SIVmac to be neutralized in macrophage cultures is unique to SIVmac and not observed with neutralization of SHIV or HIV-1.

S. Joag, O. Narayan, C. Wang, 1998, AIDS research and human retroviruses.

Initial characterization of viral sequences from a SHIV‐inoculated pig‐tailed macaque that developed AIDS

L. Foresman, D. Pinson, S. Joag, 1996, Journal of medical primatology.

Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS

L. Foresman, D. Pinson, S. Joag, 1997, Journal of virology.

Immunogenicity of the envelope GP3 protein of porcine reproductive and respiratory syndrome virus displayed on baculovirus.

Z. S. Wang, D. Tong, H. J. Liu, 2011, Acta virologica.

Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1).

L. Foresman, S. Joag, O. Narayan, 1997, Virology.

Inhibitory and enhancing effects of IFN-gamma and IL-4 on SHIV(KU) replication in rhesus macaque macrophages: correlation between Th2 cytokines and productive infection in tissue macrophages during late-stage infection.

S. Buch, D. Pinson, R. Raghavan, 2001, Cytokine.

Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques

H. McClure, L. Foresman, D. Pinson, 1996, Journal of virology.

Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus.

L. Foresman, S. Joag, O. Narayan, 1999, AIDS research and human retroviruses.

Neutralizing antibodies administered before, but not after, virulent SHIV prevent infection in macaques.

L. Foresman, S. Joag, O. Narayan, 1998, AIDS research and human retroviruses.

Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).

J. Lifson, H. McClure, M. Piatak, 2001, Virology.

Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaques.

D. Wodarz, J. Lifson, S. Buch, 2000, Virology.

Simian immunodeficiency virus SIVmac chimeric virus whose env gene was derived from SIV-encephalitic brain is macrophage-tropic but not neurovirulent

L. Foresman, D. Pinson, S. Joag, 1995, Journal of virology.

Early treatment with 9-(2-phosphonylmethoxyethyl)adenine reduces virus burdens for a prolonged period in SIV-infected rhesus macaques.

L. Foresman, D. Pinson, S. Joag, 1997, AIDS research and human retroviruses.